This one-day symposium, divided into four sessions, will bring together experts in basic, translational and clinical research working on the study of pancreatic cancer, one of the most aggressive and best characterized tumors at the molecular level. Key aspects of tumor origin, experimental models of new therapies and clinical research with new generation drugs, such as KRAS oncogene inhibitors, will be addressed.

Date: September 17, 2025

Venue: Fundación Ramón Areces C/de Vitruvio, 5 28006 MADRID

Attendance is in person (until full capacity is reached) and requires prior registration.

https://www.fundacionareces.es/fundacionareces/es/actividades/cancer-de-pancreas-retos-y-perspectivas-futuras.html